InMode (INMD) Cash & Equivalents (2018 - 2026)
InMode (INMD) posted quarterly Cash & Equivalents of $394.3 million for Q1 2026, up 170.16% year-on-year from $145.9 million in Q1 2025, and up 30.33% on a QoQ basis from $302.5 million in Q4 2025.
InMode (INMD) Cash & Equivalents (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Cash & Equivalents for 9 consecutive years, with $394.3 million the latest figure, recorded in Q1 2026.
- Quarterly Cash & Equivalents rose 170.16% year-over-year to $394.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $394.3 million (up 170.16% YoY) and the FY2025 annual result came in at $302.5 million, up 94.78% from the prior year.
- Cash & Equivalents rose to $394.3 million in Q1 2026 per INMD's latest filing, from $302.5 million in the prior quarter.
- Over the last five years, Cash & Equivalents for INMD reached as high as $394.3 million in Q1 2026 and fell as low as $44.7 million in Q1 2022.
- A 5-year average of $157.8 million and a median of $144.4 million in 2023 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2024 — Cash & Equivalents plunged 42.45% — and 2026, when it soared 170.16%.
- Year by year, Cash & Equivalents stood at $97.5 million in 2022, then soared by 48.05% to $144.4 million in 2023, then climbed by 7.56% to $155.3 million in 2024, then jumped by 94.78% to $302.5 million in 2025, then surged by 30.33% to $394.3 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $394.3 million, $302.5 million, and $252.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | 394.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 394.30 Mn |
| Dec 31, 2025 | 302.54 Mn |
| Sep 30, 2025 | 252.44 Mn |
| Jun 30, 2025 | 216.24 Mn |
| Mar 31, 2025 | 145.95 Mn |
| Dec 31, 2024 | 155.33 Mn |
| Sep 30, 2024 | 164.84 Mn |
| Jun 30, 2024 | 92.00 Mn |
| Mar 31, 2024 | 120.93 Mn |
| Dec 31, 2023 | 144.41 Mn |
| Sep 30, 2023 | 133.73 Mn |
| Jun 30, 2023 | 159.86 Mn |
| Mar 31, 2023 | 92.96 Mn |
| Dec 31, 2022 | 97.54 Mn |
| Sep 30, 2022 | 77.05 Mn |
| Jun 30, 2022 | 88.40 Mn |
| Mar 31, 2022 | 44.67 Mn |
| Dec 31, 2021 | 68.14 Mn |
| Sep 30, 2021 | 68.93 Mn |
| Jun 30, 2021 | 61.77 Mn |